Abstract
City-level estimates of the respiratory disease burden attributable to ambient ozone exposure are sparsely available, especially for low and middle-income countries. Over half of the world’s population now currently reside in urban areas, which underscores a need for improved understanding of the impact of urban air pollution on health. Until now, estimates of ozone-attributable respiratory mortality, such as those conducted by the 2017 Global Burden of Disease Study, have been constrained to a national and global scale only, due to limitations with respect to spatial resolution. However, the recent availability of air pollution datasets at a finer resolution has created an opportunity to produce such estimates at a city-level. Our approach uses year-specific 6-month average of the 8-hour daily maximum ozone concentration estimates, population, disease rates, and concentration-response relationships from the forthcoming 2019 Global Burden of Disease, to generate ozone-attributable mortality rates in cities worldwide. Results will include the number and rate of ozone-attributable respiratory mortality in hundreds of cities around the world, including temporal trends from 1990 to 2017. Preliminary results for the year 2017 demonstrate that the 6-month average of the 8-hour daily maximum ozone concentration ranges 3.5-fold (25.91 to 91.40 ppb) across the most populated 250 cities worldwide, and we expect greater heterogeneity in ozone-related health impacts since disease rates also vary. By using methods that are consistent across cities, we can compare how urban ozone mortality trends differ for cities that have experienced different patterns of growth and regulation. Our results will provide an improved understanding of the range in ozone concentrations and their associated disease burden in cities worldwide, which can be used to inform air pollution and climate change mitigation actions by individual cities and across cities that are members of urban sustainability networks.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.